Rapid Influenza Diagnostic Test (RIDT) Market By End User - Global Industry Analysis And Forecast To 2027

Published On : October 2018 Pages : 180 Category: Pharma & Healthcare Report Code : HC101585

Request Sample Inquiry Before Buying Request for Customization Check Discount

Rapid Influenza Diagnostic Test (RIDT) Market By End User (Laboratories, Hospitals & Clinics and Other End Users) - Global Industry Analysis And Forecast To 2027

Industry Outlook

The Rapid influenza diagnostic tests (RIDTs) are the immunoassays which can recognize the nearness of the viral nucleoprotein antigens in the influenza A and B in the respiratory samples, and show the outcome subjectively (positive versus negative). The advantages of these tests are; less time taken for producing the outcome in approx. in about 15 min, utilization of the tests in point-of-care and other advantages. The growth of these tests is due to; increasing aged population across the world, rising risk of influenza, rising vaccination initiatives by the government, etc. Therefore, the Rapid Influenza Diagnostic Test (RIDT) Market is anticipated to expand and has tremendous scope during the forecast period. The global Rapid Influenza Diagnostic Test (RIDT) Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Drivers & Restrains

The driving factors of the market are; increasing use of the of these tests for assisting in the treatment & diagnostic for the patients, increasing number of cases related to influenza, rising focus of the research & development for diagnosis of influenza, increasing demand for fast control & diagnosis of influenza, and other factors. The restraining factors of the market are; the instability in the regulatory system for new test approval, difference in the sensitivity level in the tests for diagnosis, and other factors.

Regional Insights

The North American region is leading the market due to rising focus of the CDC U.S. for controlling the rate of diseases, increasing technical development in the treatment, rising expenditure on the healthcare sector, etc.

Rapid Influenza Diagnostic Test (RIDT) Market, By Region

- North America
U.S.
Canada
Mexico
- Europe
Germany
UK
France
Russia
Italy
Rest of Europe
- Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific
- South America
Brazil
Argentina
Columbia
Rest of South America
- Middle East and Africa
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA

Competitive Analysis

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

Luminex Corporation
Thermo Fisher Scientific
Analytik Jena AG (Endress+Hauser AG)
Roche Diagnostics
Meridian Bioscience Inc.
Alere Inc.
Quidel Corporation
SA Scientific Ltd.
Becton
DiaSorin
Dickinson and Company

Some of the key questions answered by the report are:

What was the market size in 2017 and forecast from 2017 to 2027?
What will be the industry market growth from 2017 to 2027?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o Rapid Influenza Diagnostic Test (RIDT) Market, By End User, Estimates and Forecast, 2017-2027 ($Million)

o Laboratories

o Hospitals & Clinics

o Other End Users

o Rapid Influenza Diagnostic Test (RIDT) Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o North America

§ North America Rapid Influenza Diagnostic Test (RIDT) Market, By Country

o U.S. Rapid Influenza Diagnostic Test (RIDT) Market

o Canada Rapid Influenza Diagnostic Test (RIDT) Market

o Mexico Rapid Influenza Diagnostic Test (RIDT) Market

o Europe

§ Europe Rapid Influenza Diagnostic Test (RIDT) Market, By Country

o Germany Rapid Influenza Diagnostic Test (RIDT) Market

o UK Rapid Influenza Diagnostic Test (RIDT) Market

o France Rapid Influenza Diagnostic Test (RIDT) Market

o Russia Rapid Influenza Diagnostic Test (RIDT) Market

o Italy Rapid Influenza Diagnostic Test (RIDT) Market

o Rest of Europe Rapid Influenza Diagnostic Test (RIDT) Market

o Asia-Pacific

§ Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market, By Country

o China Rapid Influenza Diagnostic Test (RIDT) Market

o Japan Rapid Influenza Diagnostic Test (RIDT) Market

o South Korea Rapid Influenza Diagnostic Test (RIDT) Market

o India Rapid Influenza Diagnostic Test (RIDT) Market

o Southeast Asia Rapid Influenza Diagnostic Test (RIDT) Market

o Rest of Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market

o South America

§ South America Rapid Influenza Diagnostic Test (RIDT) Market, By Country

o Brazil Rapid Influenza Diagnostic Test (RIDT) Market

o Argentina Rapid Influenza Diagnostic Test (RIDT) Market

o Columbia Rapid Influenza Diagnostic Test (RIDT) Market

o Rest of South America Rapid Influenza Diagnostic Test (RIDT) Market

o Middle East and Africa

§ Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Market, By Country

o Saudi Arabia Rapid Influenza Diagnostic Test (RIDT) Market

o UAE Rapid Influenza Diagnostic Test (RIDT) Market

o Egypt Rapid Influenza Diagnostic Test (RIDT) Market

o Nigeria Rapid Influenza Diagnostic Test (RIDT) Market

o South Africa Rapid Influenza Diagnostic Test (RIDT) Market

o Rest of MEA Rapid Influenza Diagnostic Test (RIDT) Market

Table of Contents:

1. Introduction

1.1. Report Description

2. Executive Summary

2.1. Key Highlights

3. Market Overview

3.1. Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. SWOT Analysis

4. Market Analysis by Regions

4.1. North America (United States, Canada and Mexico)

4.1.1. United States Market Status and Outlook (2017-2027)

4.1.2. Canada Market Status and Outlook (2017-2027)

4.1.3. Mexico Market Status and Outlook (2017-2027)

4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1. Germany Market Status and Outlook (2017-2027)

4.2.2. France Market Status and Outlook (2017-2027)

4.2.3. UK Market Status and Outlook (2017-2027)

4.2.4. Russia Market Status and Outlook (2017-2027)

4.2.5. Italy Market Status and Outlook (2017-2027)

4.2.6. Rest of Europe Market Status and Outlook (2017-2027)

4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1. China Market Status and Outlook (2017-2027)

4.3.2. Japan Market Status and Outlook (2017-2027)

4.3.3. Korea Market Status and Outlook (2017-2027)

4.3.4. India Market Status and Outlook (2017-2027)

4.3.5. Southeast Asia Market Status and Outlook (2017-2027)

4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4. South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1. Brazil Market Status and Outlook (2017-2027)

4.4.2. Argentina Market Status and Outlook (2017-2027)

4.4.3. Columbia Market Status and Outlook (2017-2027)

4.4.4. Rest of South America Market Status and Outlook (2017-2027)

4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3. Egypt Market Status and Outlook (2017-2027)

4.5.4. Nigeria Market Status and Outlook (2017-2027)

4.5.5. South Africa Market Status and Outlook (2017-2027)

4.5.6. Turkey Market Status and Outlook (2017-2027)

4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5. Rapid Influenza Diagnostic Test (RIDT) Market, By End User

5.1. Introduction

5.2. Global Rapid Influenza Diagnostic Test (RIDT) Revenue and Market Share by End User (2017-2027)

5.2.1. Global Rapid Influenza Diagnostic Test (RIDT) Revenue and Revenue Share by End User (2017-2027)

5.3. Laboratories

5.3.1. Global Laboratories Revenue and Growth Rate (2017-2027)

5.4. Hospitals & Clinics

5.4.1. Global Hospitals & Clinics Revenue and Growth Rate (2017-2027)

5.5. Other End Users

5.5.1. Global Other End Users Revenue and Growth Rate (2017-2027)

6. Rapid Influenza Diagnostic Test (RIDT) Market, By Region

6.1. Introduction

6.2. Global Rapid Influenza Diagnostic Test (RIDT) Revenue and Market Share by Regions

6.2.1. Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Regions (2017-2027)

6.3. North America Rapid Influenza Diagnostic Test (RIDT) by Countries

6.3.1. North America Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2017-2027)

6.3.2. North America Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) by Countries (2017-2027)

6.3.3. United States

6.3.3.1. United States Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.3.4. Canada

6.3.4.1. Canada Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.3.5. Mexico

6.3.5.1. Mexico Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.4. Europe Rapid Influenza Diagnostic Test (RIDT) by Countries

6.4.1. Europe Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2017-2027)

6.4.2. Europe Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) by Countries (2017-2027)

6.4.3. Germany

6.4.3.1. Germany Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.4. France

6.4.4.1. France Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.5. UK

6.4.5.1. UK Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.6. Russia

6.4.6.1. Russia Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.7. Italy

6.4.7.1. Italy Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.8. Rest of Europe

6.4.8.1. Rest of Europe Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.5. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) by Countries

6.5.1. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2017-2027)

6.5.2. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) by Countries (2017-2027)

6.5.3. China

6.5.3.1. China Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.4. Japan

6.5.4.1. Japan Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.5. Korea

6.5.5.1. Korea Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.6. India

6.5.6.1. India Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.7. Southeast Asia

6.5.7.1. Southeast Asia Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.8. Rest of Asia-Pacific

6.5.8.1. Rest of Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.6. South America Rapid Influenza Diagnostic Test (RIDT) by Countries

6.6.1. South America Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2017-2027)

6.6.2. South America Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) by Countries (2017-2027)

6.6.3. Brazil

6.6.3.1. Brazil Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.4. Argentina

6.6.4.1. Argentina Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.5. Columbia

6.6.5.1. Columbia Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.6. Rest of South America

6.6.6.1. Rest of South America Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.7. Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) by Countries

6.7.1. Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2017-2027)

6.7.2. Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) by Countries (2017-2027)

6.7.3. Saudi Arabia

6.7.3.1. Saudi Arabia Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.4. United Arab Emirates

6.7.4.1. United Arab Emirates Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.5. Egypt

6.7.5.1. Egypt Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.6. Nigeria

6.7.6.1. Nigeria Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.7. South Africa

6.7.7.1. South Africa Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.8. Turkey

6.7.8.1. Turkey Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.9. Rest of Middle East and Africa

6.7.9.1. Rest of Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

7. Company Profiles

7.1. Luminex Corporation

7.1.1. Business Overview

7.1.2. Service Portfolio

7.1.3. Strategic Developments

7.1.4. Revenue and Market Share

7.2. Thermo Fisher Scientific

7.2.1. Business Overview

7.2.2. Service Portfolio

7.2.3. Strategic Developments

7.2.4. Revenue and Market Share

7.3. Analytik Jena AG (Endress+Hauser AG)

7.3.1. Business Overview

7.3.2. Service Portfolio

7.3.3. Strategic Developments

7.3.4. Revenue and Market Share

7.4. Roche Diagnostics

7.4.1. Business Overview

7.4.2. Service Portfolio

7.4.3. Strategic Developments

7.4.4. Revenue and Market Share

7.5. Meridian Bioscience Inc.

7.5.1. Business Overview

7.5.2. Service Portfolio

7.5.3. Strategic Developments

7.5.4. Revenue and Market Share

7.6. Alere Inc.

7.6.1. Business Overview

7.6.2. Service Portfolio

7.6.3. Strategic Developments

7.6.4. Revenue and Market Share

7.7. Quidel Corporation

7.7.1. Business Overview

7.7.2. Service Portfolio

7.7.3. Strategic Developments

7.7.4. Revenue and Market Share

7.8. SA Scientific Ltd.

7.8.1. Business Overview

7.8.2. Service Portfolio

7.8.3. Strategic Developments

7.8.4. Revenue and Market Share

7.9. Becton

7.9.1. Business Overview

7.9.2. Service Portfolio

7.9.3. Strategic Developments

7.9.4. Revenue and Market Share

7.10. DiaSorin

7.10.1. Business Overview

7.10.2. Service Portfolio

7.10.3. Strategic Developments

7.10.4. Revenue and Market Share

7.11. Dickinson and Company

7.11.1. Business Overview

7.11.2. Service Portfolio

7.11.3. Strategic Developments

7.11.4. Revenue and Market Share

8. Global Rapid Influenza Diagnostic Test (RIDT) Market Competition, by Manufacturer

8.1. Global Rapid Influenza Diagnostic Test (RIDT) Revenue and Market Share by Manufacturer (2017-2017)

8.2. Global Rapid Influenza Diagnostic Test (RIDT) Price By Region (2017-2017)

8.3. Top 5 Rapid Influenza Diagnostic Test (RIDT) Manufacturer Market Share

8.4. Market Competition Trend

9. Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.1. Global Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2027)

9.2. Rapid Influenza Diagnostic Test (RIDT) Market Forecast by Regions (2017-2027)

9.2.1. North America Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.1.1. United States Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.1.2. Canada Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.1.3. Mexico Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.2. Europe Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.2.1. Germany Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.2.2. France Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.2.3. UK Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.2.4. Russia Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.2.5. Italy Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.2.6. Rest of Europe Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.3. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.3.1. China Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.3.2. Japan Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.3.3. Korea Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.3.4. India Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.3.5. Southeast Asia Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.3.6. Rest of Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.4. South America Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.4.1. Brazil Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.4.2. Argentina Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.4.3. Columbia Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.4.4. Rest of South America Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.5. Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.5.1. Saudi Arabia Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.5.2. United Arab Emirates Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.5.3. Egypt Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.5.4. Nigeria Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.5.5. South Africa Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.5.6. Turkey Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.2.5.7. Rest of Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2017-2027)

9.3. Rapid Influenza Diagnostic Test (RIDT) Market Forecast by End User (2017-2027)

9.3.1. Rapid Influenza Diagnostic Test (RIDT) Forecast by End User (2017-2027)

9.3.2. Rapid Influenza Diagnostic Test (RIDT) Market Share Forecast by End User (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure Canada Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure Mexico Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure Germany Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure France Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure UK Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure Russia Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure Italy Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure Rest of Europe Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure China Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure Japan Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure Korea Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure India Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure Southeast Asia Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure Rest of Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure Brazil Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure Argentina Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure Columbia Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure Rest of South America Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure Saudi Arabia Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure United Arab Emirates Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure Egypt Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure Nigeria Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure South Africa Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure Turkey Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Figure Rest of Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) and Growth Rate (2017-2025)

Table Global Rapid Influenza Diagnostic Test (RIDT) Revenue and Revenue Share by End User (2017-2018)

Figure Global Laboratories Revenue and Growth Rate (2017-2018)

Figure Global Hospitals & Clinics Revenue and Growth Rate (2017-2018)

Figure Global Other End Users Revenue and Growth Rate (2017-2018)

Table Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Regions (2017-2018)

Figure North America Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure North America Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2017-2018)

Figure North America Rapid Influenza Diagnostic Test (RIDT) by Countries (2017-2018)

Figure North America Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) by Countries (2017-2018)

Figure United States Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure United States Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Canada Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure Canada Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Mexico Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure Mexico Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Europe Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure Europe Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2017-2018)

Figure Europe Rapid Influenza Diagnostic Test (RIDT) by Countries (2017-2018)

Figure Europe Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) by Countries (2017-2018)

Figure Germany Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure Germany Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure France Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure France Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure UK Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure UK Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Russia Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure Russia Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Italy Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure Italy Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Rest of Europe Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure Rest of Europe Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2017-2018)

Figure Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) by Countries (2017-2018)

Figure Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) by Countries (2017-2018)

Figure China Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure China Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Japan Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure Japan Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Korea Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure Korea Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure India Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure India Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Southeast Asia Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure Southeast Asia Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Rest of Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure Rest of Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure South America Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure South America Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2017-2018)

Figure South America Rapid Influenza Diagnostic Test (RIDT) by Countries (2017-2018)

Figure South America Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) by Countries (2017-2018)

Figure Brazil Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure Brazil Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Argentina Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure Argentina Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Columbia Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure Columbia Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Rest of South America Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure Rest of South America Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Revenue and Growth Rate (2017-2018)

Figure Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) by Countries (2017-2018)

Figure Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Revenue (Million USD) by Countries (2017-2018)

Figure Saudi Arabia Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure Saudi Arabia Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure United Arab Emirates Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure United Arab Emirates Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Egypt Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure Egypt Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Nigeria Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure Nigeria Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure South Africa Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure South Africa Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Turkey Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure Turkey Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Rest of Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Growth Rate (2017-2018)

Figure Rest of Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2017-2018)

Table Luminex Corporation Rapid Influenza Diagnostic Test (RIDT) Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Analytik Jena AG (Endress+Hauser AG) Rapid Influenza Diagnostic Test (RIDT) Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Roche Diagnostics Rapid Influenza Diagnostic Test (RIDT) Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Meridian Bioscience Inc. Rapid Influenza Diagnostic Test (RIDT) Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Alere Inc. Rapid Influenza Diagnostic Test (RIDT) Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Quidel Corporation Rapid Influenza Diagnostic Test (RIDT) Price, Revenue, Gross Margin and Market Share (2017-2017)

Table SA Scientific Ltd. Rapid Influenza Diagnostic Test (RIDT) Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Becton Rapid Influenza Diagnostic Test (RIDT) Price, Revenue, Gross Margin and Market Share (2017-2017)

Table DiaSorin Rapid Influenza Diagnostic Test (RIDT) Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Dickinson and Company Rapid Influenza Diagnostic Test (RIDT) Price, Revenue, Gross Margin and Market Share (2017-2017)

Figure Global Rapid Influenza Diagnostic Test (RIDT) Market Share by Manufacturer

Figure Global Rapid Influenza Diagnostic Test (RIDT) Revenue and Market Share by Manufacturer

Table Global Rapid Influenza Diagnostic Test (RIDT) Price by Region (2017-2017)

Figure Top 5 Rapid Influenza Diagnostic Test (RIDT) Manufacturer (Revenue) Market Share

Figure Market Competition Trend

Figure Global Rapid Influenza Diagnostic Test (RIDT) Revenue (Millions USD) and Growth Rate (2018-2025)

Table Rapid Influenza Diagnostic Test (RIDT) Market Forecast by Regions (2018-2025)

Figure North America Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure United States Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure Canada Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure Mexico Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure Europe Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure Germany Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure France Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure UK Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure Russia Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure Italy Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure Rest of Europe Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure China Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure Japan Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure Korea Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure India Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure Southeast Asia Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure Rest of Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure South America Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure Brazil Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure Argentina Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure Columbia Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure Rest of South America Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure Saudi Arabia Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure United Arab Emirates Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure Egypt Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure Nigeria Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure South Africa Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure Turkey Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure Rest of Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Market Forecast (2018-2025)

Figure Global Rapid Influenza Diagnostic Test (RIDT) Forecast by End User (2018-2025)

Figure Global Rapid Influenza Diagnostic Test (RIDT) Market Share Forecast by End User (2018-2025)

Figure Global Rapid Influenza Diagnostic Test (RIDT) Forecast by End User (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix	Supply Side	Demand Side
Primary Data Sources	Manufacturers Distributors & Wholesalers GPOs	Physicians/Specialist Healthcare Providers Consumers
Secondary Data Sources	Annual Reports/SEC Filings/ Investor Presentations/ Press Releases Government/Associations Publications	Case Studies Reference Customers

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:

Number of patients for particular device or medical procedure and
Repeated use of particular device depending on health and condition of patient

Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data	Quantitative Data (2017-2025)
Market Dynamics (Drivers, Restraints, and Challenges) Industry Trend Analysis Market Opportunities Government Policies and Regulations, Patent Analysis, and Reimbursement Policies Porter’s Five Forces and PESTLE Analysis Key Developments and Competitive Landscape	Market Assessment and Forecast Market Assessment and Forecast, By Product Market Assessment and Forecast, By Technology Market Assessment and Forecast, By Application Market Assessment and Forecast, By End User Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

Name *

Email *

Country *

Phone number *

Message *